RS
Ramkumar Srinivasan
About Ramkumar Srinivasan
Data last updated:
Ramkumar Srinivasan is a Director at Cu-V-Kar Genetic Medicine Private Limited (since 2019), Director at Hfa Formulations Private Limited (since 2021) and Managing Director at Viencee Pharma Science Private Limited (since 2022), and holds 2 more current directorships. The companies operate in Pharma and Paper. The 4 current companies with reported revenue have a combined latest revenue of ₹72.32 Cr; the largest is Cu-V-Kar Genetic Medicine Private Limited at ₹55.11 Cr (FY 2024). Earlier, Ramkumar Srinivasan was a Director at Landsteiner Pharmaceuticals Private Limited (from 2008) and Director at Consonance Technology Solutions Private Limited (from 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Aug 2019 | 2007 | ₹55.11 Cr (FY 2024) | Active | |
| Director | 29 Apr 2021 | 2015 | ₹15.65 Cr (FY 2024) | Active | |
| Managing Director | 21 Mar 2022 | 2017 | ₹1.54 Cr (FY 2024) | Active | |
| Director | 05 Jul 2023 | 2023 | ₹1.1 Lakh (FY 2025) | Active | |
| Director | 20 Sep 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Feb 2008 | 2008 | Strike Off | ||
| Director | 30 Sep 2019 | 2008 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ramkumar Srinivasan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Muthukaruppan Srinivasan | 03299981 | Cu-V-Kar Genetic Medicine Private Limited , Hfa Formulations Private Limited and 3 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramkumar Srinivasan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramkumar Srinivasan
Ramkumar Srinivasan currently holds 5 directorships: Cu-V-Kar Genetic Medicine Private Limited (Director, since 09 Aug 2019, revenue ₹55.11 Cr (FY 2024)); Hfa Formulations Private Limited (Director, since 29 Apr 2021, revenue ₹15.65 Cr (FY 2024)); Viencee Pharma Science Private Limited (Managing Director, since 21 Mar 2022, revenue ₹1.54 Cr (FY 2024)); Cu-V-Kar Pharmacuticals Private Limited (Director, since 05 Jul 2023, revenue ₹1.1 Lakh (FY 2025)); Mm Pharma Medicines Private Limited (Director, since 20 Sep 2023).
Ramkumar Srinivasan was first appointed on 20 Feb 2008 as Director at Landsteiner Pharmaceuticals Private Limited. The most recent appointment on record is 20 Sep 2023 at Mm Pharma Medicines Private Limited.
The 4 current companies of Ramkumar Srinivasan that report revenue have a combined latest revenue of ₹72.32 Cr: Cu-V-Kar Genetic Medicine Private Limited ₹55.11 Cr (FY 2024); Hfa Formulations Private Limited ₹15.65 Cr (FY 2024); Viencee Pharma Science Private Limited ₹1.54 Cr (FY 2024); Cu-V-Kar Pharmacuticals Private Limited ₹1.1 Lakh (FY 2025).
Ramkumar Srinivasan held 2 earlier board appointments: Landsteiner Pharmaceuticals Private Limited (Director, from 20 Feb 2008); Consonance Technology Solutions Private Limited (Director, from 30 Sep 2019).
The current boards of Ramkumar Srinivasan's companies include Muthukaruppan Srinivasan (Cu-V-Kar Genetic Medicine Private Limited).